Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
Middlefield Healthcare Dividend ETF Distributions
-
Dimensional Fund Advisors Ltd. : Form 8.3 - RENEWI PLC - Ordinary Shares
-
Dimensional Fund Advisors Ltd. : Form 8.3 - JOHN WOOD GROUP PLC - Ordinary Shares
-
Dimensional Fund Advisors Ltd. : Form 8.3 - AMERICAN AXLE & MFG HOLDINGS - Ordinary Shares
-
MINT Income Fund Distributions
-
Clearmind Medicine Completes the Initiation of its Alcohol Use Disorder Phase I/IIa Clinical Trial at all Current Clinical Sites
-
Sustainable Infrastructure Dividend ETF Distributions
-
Real Estate Split Corp. Class A Distribution
-
Sustainable Innovation & Health Dividend Fund Distributions
-
XPENG Unveils AI-Driven Mobility Revolution at Auto Shanghai 2025
-
United Arab Emirates Ministry of Health and Prevention Approves Biomerica’s Fortel® Ulcer Test for Detection of H. pylori Infection
-
Bionic P&O Chosen as First Distributor of Ekso Indego® Personal Within the Orthotics & Prosthetics Industry
-
Wearable Devices Secures U.S. Patent for Combined Voice and Gesture Control
-
OneMedNet and Protege Partner to Advance the Future of AI-Driven Healthcare with Real-Time, Multimodal Data
-
New Episode Now Streaming on Alpha Liquid Podcast: Proph3t, Pseudonymous Founder of MetaDAO, Unpacks Futarchy and the Future of Governance
-
Apollo Funds Form $220 Million Community Solar Joint Venture with Bullrock Energy Ventures
-
Hospice Choices: VITAS® Healthcare Expands in Austin, Texas
-
Puma Exploration Launches its 2025 Exploration Program at Williams Brook
-
WEBPRO Introduces Rare Domain Names for Sale Ahead of Auction
-
Elanders AB: Report from the Annual General Meeting 2025
-
Delinea Unveils Enterprise-Grade Cloud-Native Security Capabilities to Help Safeguard and Scale AI Innovation
-
Greenhouse Trial Confirms Superior Performance of Windfall Bio’s Organic Fertilizer
-
VivoSim to Carry Forward Organovo 3D Bioprinting
-
Rezolute Announces Pricing of Offering of $90 Million of Common Stock and Pre-Funded Warrants
-
Infrastructure Dividend Split Corp. Class A and Preferred Distributions
-
NATIONAL ORGANIZATIONS UNITE TO PREPARE EARLY CHILDCARE FACILITIES FOR RISING INCIDENCE OF FOOD ALLERGIES
-
Qitone Launches Flavorless Pro-Ketone Powder Backed by Clinical Research
-
Marotta Controls Returns to the Moon with the Firefly Aerospace Blue Ghost Lunar Lander
-
E Split Corp. Class A Distribution
-
Hanover Bancorp, Inc. Reports First Quarter 2025 Results Highlighted by Accelerated Margin Expansion, Improved Credit Quality Metrics & Successful Core Banking System Conversion
-
The Oncology Institute Announces First Quarter 2025 Earnings Release Date and Conference Call
-
Hanover Bancorp, Inc. Reports First Quarter 2025 Results Highlighted by Accelerated Margin Expansion, Improved Credit Quality Metrics & Successful Core Banking System Conversion
-
Phathom Pharmaceuticals to Report First Quarter 2025 Financial Results and Provide Business Update on Thursday, May 1, 2025
-
Global Water Resources Sets First Quarter 2025 Conference Call for Thursday, May 15, 2025 at 1:00 p.m. ET
-
Credit Agricole Sa: ORDINARY AND EXTRAORDINARY GENERAL MEETING OF CRÉDIT AGRICOLE S.A. OF 14 May 2025
-
Cerence AI and MediaTek Partner to Introduce Multi-Modal Language Models Running on the Edge, Built on NVIDIA
-
Aemetis India Plant Visited by U.S. Consul General
-
Asure Software Launches New Canadian Payroll Tax Solution to Support Global Enterprises
-
Rectify Pharma to Share Preclinical Data Highlighting Progress in Hepatobiliary Program at EASL 2025
-
Miggo Raises $17M Series A to Replace Patch-and-Pray With Real-Time Application Resilience
-
WaveMaker Enhances Custom Mobile App Experiences for Influencer MVNOs Through AT&T Collaboration
-
Protara Therapeutics to Host Conference Call and Webcast to Review Interim Data from Phase 2 ADVANCED-2 Trial of TARA-002 in Patients with NMIBC on Monday, April 28, 2025
-
Maxon Selects 2Checkout to Drive Global Online Sales Expansion and Boost Operational Efficiency
-
Daré Bioscience to Present at the Fierce Pharma Engage Summit on Breaking Barriers and Building Access: Communicating Bold Moves in Women’s Health Innovation
-
Recce Pharmaceuticals Receives Approval for Additional Phase II Trial of RECCE® 327 Topical Gel for Diabetic Foot Infections
-
Tessell Named to CRN’s 2025 Big Data 100 List for Its AI-Powered Multi-Cloud DBaaS Platform
-
Feedonomics Simplifies First-Party Selling for Large Brands, Manufacturers and Distributors with New Amazon Vendor Central Integration
-
Cloudbrink Supercharges Work from Anywhere with High-Performance ZTNA in LATAM, Korea, and Africa Through Strategic Channel Expansion
-
ManTech Names Eric Mellinger Vice President of Business Development for Defense Sector
-
UNITY Biotechnology Announces Publication in NEJM Evidence Highlighting the Potential of Senolytic Therapeutics to Provide Long-Term Improvements in Vision in DME

